Magzter GOLDで無制限に

Magzter GOLDで無制限に

9,500以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

HC asks CCSEA to inspect Palamur Bio

Chronicle Pharmabiz

|

July 17, 2025

THE Delhi High Court (HC) has asked the Committee for Control and Supervision of Experiments on Animals (CCSEA) to conduct an inspection along with the representatives of the People for the Ethical Treatment of Animals India (PETA India) and submit a status report within four weeks regarding the animal experiments and related issues in Telangana-based Palamur Biosciences.

- Our Bureau, New Delhi

The Court also restrained the company from procuring or housing any new animals at its facility till the exercise is conducted.

The order was issued in connection with a petition filed by PETA India against CCSEA and Palamur Biosciences, alleging failure on the part of the Committee to address the alleged systematic failure and blatant violations of animal rights and also regulatory non-compliances at the hands of the company.

Chronicle Pharmabiz からのその他のストーリー

Chronicle Pharmabiz

Miltenyi Biotec, THSTI to set up cell mfg programme

IN a milestone step toward strengthening India's cell and gene therapy (CGT) ecosystem, Miltenyi Biotec, a global leader in CGT technologies, has signed a Letter of Intent (LOI) with the Translational Health Science and Technology Institute (THSTI) to establish India's first hands-on training programmes in clinical cell manufacturing.

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

MDC asks Abbott Healthcare to avoid negligence while filing price details

THE Multi Disciplinary Committee (MDC) of Experts, which advises the National Pharmaceutical Pricing Authority (NPPA) on pricing matters, has directed Abbott Healthcare to avoid negligence in filing proper details while submitting the price related details in the Integrated Pharmaceutical Database Management System (IPDMS).

time to read

1 mins

August 21, 2025

Chronicle Pharmabiz

Greenspace Herbs unveils 'Quantum Ayurveda'

GREENSPACE Herbs, a leading botanical ingredients company, announced the commercial launch of Quantum Ayurveda, an advanced technology platform that enhances traditional herbal ingredients using quantum resonance principles.

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

Chronicle Pharmabiz

Gandhi Automations ensuring clean room integrity with high-speed doors

GANDHI Automations Pvt Ltd offers prime clean reset high-speed doors to ensure clean room integrity, minimize air permeability and leakages.

time to read

3 mins

August 21, 2025

Chronicle Pharmabiz

Haryana DC officials raid unregistered clinic in Karnal

In a swift response to a complaint regarding illegal medical practice, a team of health and drug control officials raided an unregistered clinic in Karnal in Haryana, leading to the arrest of an individual found to be practicing medicine without proper medical qualification.

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

Guj attracts investments from 100 cr to 5,000 cr

GUJARAT has attracted big ticket investments from MNCs and Indian companies as part of 376 Memorandum of Understandings (MoUs) ranging from Rs. 100 crore to Rs. 5,000 crore, informed Dr H G Koshia, Commissioner of the Gujarat Food & Drug Control Administration (FDCA).

time to read

1 min

August 21, 2025

Chronicle Pharmabiz

'Industry's diversification to EU markets is acting as a buffer against US trade shocks'

INDIAN Pharma industry's diversification into European markets is acting as a buffer against US trade shocks, says Parag Bhatia, director, Laborate Pharmaceuticals.

time to read

2 mins

August 21, 2025

Chronicle Pharmabiz

Pharma, CROs turn to hybrid cloud infra to safeguard patient information

PHARMA companies and clinical research organizations (CROs) are increasingly adopting hybrid cloud infrastructure to safeguard sensitive patient information.

time to read

2 mins

August 21, 2025

Chronicle Pharmabiz

'India's PLI scheme transforms pharma industry from policy to practice'

INDIA'S production linked incentive (PLI) scheme has emerged as a transformative policy aimed at revitalizing the pharmaceutical sector and its global competitiveness.

time to read

2 mins

August 21, 2025

Chronicle Pharmabiz

CDSCO cancels Proteos' Indian agent's import regn

THE Cosmetics Division of the Central Drugs Standard Control Organisation (CDSCO) has cancelled the registration certificate of NKG Advisory Business and Consulting Services to sell the cosmetic products of Spanish cosmetics maker Proteos Biotech, based on the former's request.

time to read

1 min

August 21, 2025

Listen

Translate

Share

-
+

Change font size